NPCE
Neuropace IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$540.04M
P/E Ratio
—
EPS
$-0.65
Beta
1.88
52W High
$19.60
52W Low
$7.56
50-Day MA
$16.16
200-Day MA
$14.12
Dividend Yield
—
Profit Margin
-21.70%
Forward P/E
—
PEG Ratio
—
About Neuropace Inc
NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
Fundamentals
| Revenue (TTM) | $99.53M |
| Gross Profit (TTM) | $77.93M |
| EBITDA | $-16.51M |
| Operating Margin | -25.20% |
| Return on Equity | -111.40% |
| Return on Assets | -10.00% |
| Revenue/Share (TTM) | $2.99 |
| Book Value | $0.43 |
| Price-to-Book | 37.28 |
| Price-to-Sales (TTM) | 5.43 |
| EV/Revenue | 5.58 |
| EV/EBITDA | -16.94 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -2.00% |
| Shares Outstanding | $34.09M |
| Float | $23.30M |
| % Insiders | 4.03% |
| % Institutions | 96.28% |
Historical Volatility
HV 10-Day
31.49%
HV 20-Day
40.00%
HV 30-Day
64.17%
HV 60-Day
54.21%
HV Rank
74.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($20.00 target)
1
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026